Correction to: Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL

Lignende værker

• Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria
  af: Katelyn E. Madigan, et al.
  Udgivet: (2023-12-01)
• Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria
  af: Elena Di Pierro, et al.
  Udgivet: (2022-01-01)
• Validation of the sunlight exposure diary and the erythropoietic protoporphyria impact questionnaire (EPIQ)
  af: Hetanshi Naik, et al.
  Udgivet: (2025-09-01)
• Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
  af: Anna-Elisabeth Minder, et al.
  Udgivet: (2023-04-01)
• Long-term iron supplementation in four patients with X-linked erythropoietic protoporphyria: associations with serum proteins and erythrocyte protoporphyrin levels—a single-centre retrospective study
  af: Anna-Elisabeth Minder, et al.
  Udgivet: (2025-02-01)